Fight Cancer with HOPE.

Supporting the Fighters.

Admiring the Survivors.

Honoring the Taken.

Nothing is more beautiful than healthy skin. But over your lifetime the damaging effects of ultraviolet rays—from the sun, tanning beds and other sources—can lead to basal cell carcinoma (BCC) or squamous cell carcinoma (SCC). Nearly three million Americans are diagnosed with Skin Cancer each year—making it the most common type of all cancers. With the number of cases expected to grow, more people will undergo basal cell carcinoma treatment. Although it is the mildest form of skin cancer and rarely spreads to vital organs, rare aggressive forms of the disease can be deadly if not treated properly.

For years, traditional basal cell carcinoma treatment—including Mohs—has involved invasive cutting through healthy tissue, painful healing, lengthy recovery and unsightly scarring. Sensus Healthcare is changing all that with a basal cell treatment option with SRT. The revolutionary SRT-100 Vision utilizes SRT (superficial radiation therapy) which kills basal cell carcinoma and squamous cell carcinoma at the source. It a few, short treatments you will be non-melanoma skin cancer free thanks to Sensus’ SRT-100 Vision.

Now patients undergoing basal cell carcinoma treatment don’t have to worry about permanent disfigurement, nerve damage or injury to muscles due to surgery. Find more about the best skin cancer treatment option today.

Sensus Healthcare’s Superficial Radiation Therapy (SRT) devices are giving non-melanoma skin cancer and keloid patients new hope. With SRT, patients can expect to cure their non-melanoma skin cancer safely and get rid of keloids effectively. Check out our studies below: